AC Immune stock was absolutely crushed on Wednesday after the firm announced disappointing results from its midstage Alzheimer’s disease study.
China's Shanghai exchange fell into bear territory Tuesday, another signal that the government's efforts to manage the economy are not having their intended effect. Can China withstand an all-out...
Xiaomi had been looking forward to raising $10 billion in two IPOs, one in Hong Kong and one in Shanghai. But the Chinese smartphone maker has delayed its Shanghai offering while it sorts out a...
Shares of LDR skyrocketed in Tuesday's session following the definitive agreement for Zimmer Biomet to acquire the company for $1 billion.
It seems Biogen's closely watched Alzheimer's drug candidate, aducanumab, has fallen short of analyst and investor expectations.
Merrill Lynch sees Biogen returning to these heightened levels, with its pipeline acting as the primary catalyst.
Cedar Shopping Centers, Inc. (NYSE CDR) has filed to sell up to $1 billion in mixed securities via a public offering of securities.  It can sell any combination of common stock, preferred stock,...
The brokerage and research firm Stifel Nicolaus has decided that REITS are either at or are close to their inflection points.  REITs have been very strong performers in light of many large...
ANAD started as Outperform at Credit Suisse.ASCA cut to Underweight at Prudential.AU cut to Neutral at HSBC.BELM cut to Neutral at Baird.BRCM raised to Buy at Stifel Nicolaus.
(AAPL) Apple delayed its 10-K filing over options review.(ADBE) Adobe trading up 6% after beating earnings estimates.(AEZ) American )&G positive in Business Week.(AFFY) Affymax 3.7M underwriting...
(AGN) Allergan noted as Buy by Cramer on MAD MONEY after he interviewed the CEO on TV.(ALNY) Alnylam Pharma filed to sell 4.7M shares.(AQNT) aQuantive is acquiring privately-held Accipiter for...